Kinetics of Inhibitor Cycling Underlie Therapeutic Disparities between EGFR-Driven Lung and Brain Cancers
Krister J. Barkovich(University of California San Diego), William A. Weiss(City College of San Francisco), Sujatmi Hariono(Howard Hughes Medical Institute), Kevan M. Shokat(Howard Hughes Medical Institute), Jimmy A. Blair, Theodore Nicolaides(Caris Life Sciences (United States)), Jie Zhang(Jilin University), Qi‐Wen Fan(University of California, San Francisco), Adam L. Garske(Howard Hughes Medical Institute)
Cited by 55
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
The translational landscape of mTOR signalling steers cancer initiation and metastasis
|Nature|2012|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k